Michael Brady & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Michael Brady & Co's ABBV Position: Q3 2026 in Review
Michael Brady & Co held its AbbVie (ABBV) position steady in Q3 2026 at 3,484 shares worth $911K. The position accounts for 0.83% of the portfolio, ranked #20.
Michael Brady & Co first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Michael Brady & Co held 3,484 shares of AbbVie worth $911K as of Q3 2026.
- Michael Brady & Co left its AbbVie share count unchanged in Q3 2026.
- AbbVie made up 0.83% of Michael Brady & Co's portfolio in Q3 2026, its #20 holding.
- Michael Brady & Co first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Michael Brady & Co's 13F filing for Q3 2026, filed 23 Oct 2026.